Evidence map›Paper›PMID 29575351›Full record

ReviewPharmacoepidemiology and drug safety2020

Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article.

J M Gamble, Robyn L Traynor, Anatoliy Gruzd, Philip Mai, Colin R Dormuth, Ingrid S Sketris

Abstract readReview
In one paragraph

Review in Pharmacoepidemiology and drug safety, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The correlation between altmetric score and traditional measures of article impact for studies pertaining to spine trauma.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J M GambleFaculty of Science, School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.ORCID 0000-0001-6891-8721
Robyn L TraynorDepartment of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.ORCID 0000-0002-1386-708X
Anatoliy GruzdTed Rogers School of Management, Ryerson University, Toronto, Ontario, Canada.ORCID 0000-0003-2366-5163
Philip MaiTed Rogers School of Management, Ryerson University, Toronto, Ontario, Canada.
Colin R DormuthFaculty of Medicine, Department of Anesthesiology, Pharmacology, & Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
Ingrid S SketrisFaculty of Health Professions, College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada.ORCID 0000-0003-1820-5883

Funding

CIHR DSE-111845
6 · The paper itself

Abstract

purposeTo provide an overview of altmetrics, including their potential benefits and limitations, how they may be obtained, and their role in assessing pharmacoepidemiologic research impact.

methodsOur review was informed by compiling relevant literature identified through searching multiple health research databases (PubMed, Embase, and CIHNAHL) and grey literature sources (websites, blogs, and reports). We demonstrate how pharmacoepidemiologists, in particular, may use altmetrics to understand scholarly impact and knowledge translation by providing a case study of a drug-safety study conducted by the Canadian Network of Observational Drug Effect Studies.

resultsA common approach to measuring research impact is the use of citation-based metrics, such as an article's citation count or a journal's impact factor. "Alternative" metrics, or altmetrics, are increasingly supported as a complementary measure of research uptake in the age of social media. Altmetrics are nontraditional indicators that capture a diverse set of traceable, online research-related artifacts including peer-reviewed publications and other research outputs (software, datasets, blogs, videos, posters, policy documents, presentations, social media posts, wiki entries, etc).

conclusionCompared with traditional citation-based metrics, altmetrics take a more holistic view of research impact, attempting to capture the activity and engagement of both scholarly and nonscholarly communities. Despite the limited theoretical underpinnings, possible commercial influence, potential for gaming and manipulation, and numerous data quality-related issues, altmetrics are promising as a supplement to more traditional citation-based metrics because they can ingest and process a larger set of data points related to the flow and reach of scholarly communication from an expanded pool of stakeholders. Unlike citation-based metrics, altmetrics are not inherently rooted in the research publication process, which includes peer review; it is unclear to what extent they should be used for research evaluation.

Indexed as

Databases, FactualPharmacovigilanceTranslational Research, BiomedicalCanadaHumansalternative metricsaltmetricsbibliometricscitation metricsknowledge translationpharmacoepidemiologyresearch evaluationresearch uptakescholarly impact

Identifiers

PMID29575351
PMCPMC7004200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.